Valley Wealth Managers
VRTX icon

Valley Wealth Managers’s Vertex Pharmaceuticals VRTX Stock Holding History

Valley Wealth Managers’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.1M Buy
51,753
+424
+0.8% +$217K 1.54% 24
2026
Q2 		$25.5M Buy
51,329
+1,190
+2% +$527K 1.47% 23
2026
Q1 		$22.4M Sell
50,139
-812
-2% -$379K 1.44% 30
2025
Q4 		$23.1M Buy
50,951
+1,132
+2% +$488K 1.48% 27
2025
Q3 		$19.5M Buy
49,819
+1,130
+2% +$472K 1.29% 38
2025
Q2 		$21.7M Sell
48,689
-795
-2% -$366K 1.56% 24
2025
Q1 		$24M Sell
49,484
-1,040
-2% -$485K 1.82% 14
2024
Q4 		$20.3M Buy
50,524
+50
+0.1% +$23.2K 1.52% 24
2024
Q3 		$23.5M Sell
50,474
-1,006
-2% -$483K 1.74% 11
2024
Q2 		$24.1M Sell
51,480
-3,723
-7% -$1.62M 1.92% 8
2024
Q1 		$23.1M Sell
55,203
-4,093
-7% -$1.73M 1.74% 13
2023
Q4 		$24.1M Sell
59,296
-1,600
-3% -$591K 1.88% 8
2023
Q3 		$21.2M Sell
60,896
-3,170
-5% -$1.11M 1.77% 11
2023
Q2 		$22.5M Sell
64,066
-4,268
-6% -$1.44M 2.02% 10
2023
Q1 		$21.5M Sell
68,334
-3,913
-5% -$1.17M 1.96% 11
2022
Q4 		$20.9M Sell
72,247
-6,879
-9% -$2.1M 1.94% 14
2022
Q3 		$22.9M Sell
79,126
-6,699
-8% -$1.93M 2.29% 3
2022
Q2 		$24.2M Sell
85,825
-4,678
-5% -$1.25M 2.26% 4
2022
Q1 		$23.6M Sell
90,503
-4,735
-5% -$1.12M 1.97% 11
2021
Q4 		$20.9M Sell
95,238
-1,125
-1% -$219K 1.68% 19
2021
Q3 		$17.5M Buy
+96,363
New +$18.8M 1.52% 31
2017
Q1 		– Sell
-32
Closed -$2K – 247
2016
Q4 		$2K Buy
+32
New +$2.6K ﹤0.01% 231

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Valley Wealth Managers's VRTX Position: Q3 2026 in Review

Valley Wealth Managers increased its Vertex Pharmaceuticals (VRTX) stake by 0.83% in Q3 2026, buying an estimated $217K and bringing the position to 51,753 shares worth $27.1M. The position accounts for 1.54% of the portfolio, ranked #24.

Valley Wealth Managers first reported a position in VRTX in Q4 2016 and has held it in 22 quarters since. 386 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Valley Wealth Managers held 51,753 shares of Vertex Pharmaceuticals worth $27.1M as of Q3 2026.
  • Valley Wealth Managers bought 424 Vertex Pharmaceuticals shares in Q3 2026, an estimated $217K.
  • Vertex Pharmaceuticals made up 1.54% of Valley Wealth Managers's portfolio in Q3 2026, its #24 holding.
  • Valley Wealth Managers first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 22 quarters since.
  • 386 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Valley Wealth Managers's 13F filing for Q3 2026, filed 9 Oct 2026.